BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7220429)

  • 1. Pancreatic oncofoetal antigen in pancreatic cancer.
    Hobbs JR; Branfoot AC; Knapp ML
    Practitioner; 1980 Oct; 224(1348):1023-7. PubMed ID: 7220429
    [No Abstract]   [Full Text] [Related]  

  • 2. [The tumor-associated antigen CA 19-9 in the differential diagnosis and course control of malignancies of the pancreas and the gastrointestinal tract].
    Klapdor R; Greten H
    Dtsch Med Wochenschr; 1984 Dec; 109(50):1935-9. PubMed ID: 6210188
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum tissue polypeptide antigen in the differential diagnosis of chronic pancreatitis and exocrine pancreatic tumors. Preliminary results].
    Ruibal A; Encabo G
    Rev Esp Oncol; 1983; 30(3):313-6. PubMed ID: 6571374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antigens in the blood serum in pancreatic cancer].
    Vel'bri SK
    Vopr Onkol; 1979; 25(11):28-31. PubMed ID: 516561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous evaluation of a pancreas-specific antigen and a pancreatic cancer-associated antigen in pancreatic carcinoma.
    Loor R; Kuriyama M; Bodziak ML; Inaji H; Douglass HO; Berjian R; Nicolai JJ; Tytgat GN; Chu TM
    Cancer Res; 1984 Aug; 44(8):3604-7. PubMed ID: 6744282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pancreatic oncofetal antigen (POA)].
    Mugitani H; Furue H; Kako M; Hirota F; Fuse K; Takahashi T; Sakamoto K; Yamada K; Suminaga M; Ezaki M; Judo R
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1737-43. PubMed ID: 6882002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic value of serum Ca 19-9 antigen in chronic pancreatitis and pancreatic adenocarcinoma].
    Nouts A; Lévy P; Voitot H; Bernades P
    Gastroenterol Clin Biol; 1998 Feb; 22(2):152-9. PubMed ID: 9762189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody-defined human pancreatic cancer-associated antigens.
    Schmiegel WH; Kalthoff H; Arndt R; Gieseking J; Greten H; Klöppel G; Kreiker C; Ladak A; Lampe V; Ulrich S
    Cancer Res; 1985 Mar; 45(3):1402-7. PubMed ID: 3882225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The contribution of CA 19-9 in the differential diagnosis between chronic pancreatitis and cancer of the pancreas].
    Van Gossum M; Delanghe A; Gerard M; Delcourt A; Deltenre M
    Acta Gastroenterol Belg; 1987; 50(1):91-4. PubMed ID: 3480672
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnostic significance of pancreatic antigen determination].
    Velbri S; Männiste J
    Z Gesamte Inn Med; 1980 Sep; 35(17):684-8. PubMed ID: 6162288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CA 19-9 and cancer of the pancreas. Critical review of the literature].
    Delcourt A
    Acta Gastroenterol Belg; 1987; 50(1):1-8. PubMed ID: 3321822
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunologic markers of pancreatic cancer in humans].
    Kulagin PP; Chalov VV
    Vopr Onkol; 1983; 29(8):62-7. PubMed ID: 6193639
    [No Abstract]   [Full Text] [Related]  

  • 13. Pancreatic oncofoetal antigen (POA): its frequency and localisation in humans.
    Hobbs JR; Knapp ML; Branfoot AC
    Oncodev Biol Med; 1980 Aug; 1(1):37-48. PubMed ID: 7279697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Attention to CA 19.9 in alcoholics. Apropos of a case].
    Giovannini M; Penalvert F; Maillot A; Escoffier JM; Botta D; Gauthier A
    Ann Gastroenterol Hepatol (Paris); 1987 Dec; 23(7):393. PubMed ID: 3481241
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor-associated antigen in human pancreatic cancer.
    Schultz DR; Yunis AA
    J Natl Cancer Inst; 1979 Apr; 62(4):777-85. PubMed ID: 85737
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biohumeral markers in the diagnosis of pancreatic carcinoma].
    Panucci A; Del Favero G; Falmis C; Brosolo P; Basso D; Pedrazzoli S; Baccaglini U; Marchioro L; Bonvilini P; Naccarato R
    Recenti Prog Med; 1985; 76(7-8):385-91. PubMed ID: 3865269
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of micro-leukocyte adherence inhibition as an immunodiagnostic test for pancreatic cancer.
    Goldrosen MH; Russo AJ; Howell JH; Leveson SH; Moore MC; Holyoke ED; Douglass HO
    Cancer Res; 1979 Feb; 39(2 Pt 2):633-7. PubMed ID: 367589
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative analysis of diffusion-weighted magnetic resonance imaging of the pancreas: usefulness in characterizing solid pancreatic masses.
    Lee SS; Byun JH; Park BJ; Park SH; Kim N; Park B; Kim JK; Lee MG
    J Magn Reson Imaging; 2008 Oct; 28(4):928-36. PubMed ID: 18821618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of pancreas-specific antigen in immunodiagnosis of pancreatic cancer.
    Loor R; Nowak NJ; Manzo ML; Douglass HO; Chu TM
    Clin Lab Med; 1982 Sep; 2(3):567-78. PubMed ID: 6754226
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of a serum pancreatic tumor marker: the carbohydrate antigen C.A. 19-9].
    Vincent D; Venot J; Catanzano G; Clément MN; Piquet MF; Veyriras E; Beck C
    Ann Med Interne (Paris); 1985; 136(2):142-4. PubMed ID: 3865571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.